Enzolytics Inc (ENZC)

[Wisdom of Locke]

My response is simple:

Small changes in price don’t matter to me much. ENZC is a pre-revenue drug development company. Any value the company has is based on projections, not discounted cash flow.

If the intellectual property of ENZC isn’t valid, the stock is overpriced. But, if the IP is valid, the stock is wildly underpriced.

The company only has to hit on ITV-1…….or…….monoclonal antibodies……or……the MS drug…..or……the AI……or…….IPF Immune……or …..something else.

I can’t 100% say that there will be a hit, but, in my opinion, the odds are terrific. Then, the stock will soar.


Sorry for the delay in responding.